Contrast-enhanced magnetic resonance angiography: Evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 tesla and 3.0 tesla

Investigative Radiology

Volumn 43, Issue 12, 2008, Pages 837-842

  Peldschus, Kersten ^a   Hamdorf, Mareike ^a   Robert, Philippe ^b   Port, Marc ^b   Graessner, Joachim ^c   Adam, Gerhard ^a   Herborn, Christoph U ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Laboratoire Guerbet   (France)

^c SIEMENS AG   (Germany)

Author keywords

Contrast media; Field strength; Gadolinium; Magnetic resonance angiography; Relaxivity

Indexed keywords

GADOTERATE MEGLUMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; P 846; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DIAGNOSTIC AGENT; MEGLUMINE; ORGANOMETALLIC COMPOUND; P846 COMPOUND;

ANIMAL EXPERIMENT; AORTA; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXPERIMENTAL RABBIT; FEMALE; IMAGE QUALITY; IMAGING SYSTEM; INFERIOR CAVA VEIN; KIDNEY CORTEX; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RATING SCALE; SIGNAL NOISE RATIO; ABDOMINAL AORTA; ANIMAL; COMPARATIVE STUDY; EVALUATION; HISTOLOGY; IMAGE ENHANCEMENT; METHODOLOGY; RAT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; AORTA, ABDOMINAL; CONTRAST MEDIA; FEMALE; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 59649085591     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181852158     Document Type: Article

References (26)

1. Yucel EK, Anderson CM, Edelman RR, et al. AHA scientific statement. Magnetic resonance angiography: update on applications for extracranial arteries. Circulation. 1999;100:2284-2301.
2. Nael K, Laub G, Finn JP. Three-dimensional contrast-enhanced MR angiography of the thoraco-abdominal vessels. Magn Reson Imaging Clin N Am. 2005;13:359-380.
3. Toth E, Helm L, Merbach AE. Relaxivity of MRI contrast agents. Top Curr Chem. 2002;211:61-101.
4. Zhang H, Maki JH, Prince MR. 3D contrast-enhanced MR angiography. J Magn Reson Imaging. 2007;25:13-25.
5. EU patent: MXPA01011439 (2002-06-04) Marc Port. Bicyclic polyami-noacid metal complexes, method for preparing same and use in medical imaging.
6. Vautier J, Heilmann M, Dimicoli JL, et al. Characterization of an experimental setup to study in vitro permeability properties of macro-molecular contrast agents by DCE-MRI. Proc Intl Soc Mag Reson Med. Berlin, 2007;217.
7. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724.
8. Merkle EM, Dale BM, Barboriak DP. Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. Acad Radiol. 2007;14:795-803.
9. Allkemper T, Heindel W, Kooijman H, et al. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall super-paramagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla. Invest Radiol. 2006;41:97- 104.
10. Lee VS, Hecht EM, Taouli B, et al. Body and Cardiovascular MR Imaging at 3.0 T. Radiology. 2007;244:692-705.
11. Nael K, Fenchel M, Krishnam M, et al. 3.0 Tesla high spatial resolution contrast-enhanced magnetic resonance angiography (CE-MRA) of the pulmonary circulation: initial experience with a 32-channel phased array coil using a high relaxivity contrast agent. Invest Radiol. 2007;42:392-398.
12. Bi X, Carr JC, Li D. Whole-heart coronary magnetic resonance angiog- raphy at 3 Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent. Magn Reson Med. 2007;58:l-7.
13. Herborn CU, Watkins DM, Baumann S, et al. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T. Invest Radiol. 2007;42:622-628.
14. Nael K, Fenchel M, Krishnam M, et al. High-spatial-resolution whole-body MR angiography with high-acceleration parallel acquisition and 32-channel 3.0-Tunit: initial experience. Radiology. 2007;242:865-872.
15. Kramer H, Michaely HJ, Matschl V, et al. High-resolution magnetic resonance angiography of the lower extremities with a dedicated 36-element matrix coil at 3 Tesla. Invest Radiol. 2007;42:477-483.
16. Sodickson DK, Hardy CJ, Zhu Y, et al. Rapid volumetric MRI using parallel imaging with order-of-magnitude accelerations and a 32-ele-ment RF coil array: feasibility and implications. Acad Radiol. 2005;12: 626-635.
17. Nijenhuis RJ, Leiner T, Cornips EM, et al. Spinal cord feeding arteries at MR angiography for thoracoscopic spinal surgery: feasibility study and implications for surgical approach. Radiology. 2004;233:541-547.
18. Prosst RL, Fernandez ED, Neff W, et al. Evaluation of MR-angiography for pre-operative assessment of living kidney donors. Clin Transplant. 2005;19:522-526.
19. Leiner T, Herborn CU, Goyen M. Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide. Eur Radiol. 2007;17:1921-1923.
20. Port M, Idee JM, Medina C, et al. Efficiency, thermodynamic and kinetic stability of marketed gadolonium chelates and their possible clinical consequences: a critical review. Biometals. 2008;21:469-490.
21. Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology. 2007;245:168-175.
22. Bremerich J, Bilecen D, Reimer P. MR angiography with blood pool contrast agents. Eur Radiol. 2007;17:3017-24.
23. Tombach B, Reimer P, Bremer C, et al. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed. 2004; 17:500-506.
24. Nikolaou K, Kramer H, Grosse C, et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology. 2006;241:861-872.
25. Klessen C, Hein PA, Huppertz A, et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol. 2007;42:659-664.
26. Fink C, Bock M, Kiessling F, et al. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs.0.5 M gadopentetate dimeglumine. J Magn Reson Imaging. 2004;19:202-208.